FDA Approved: ALVESCO — Original Application (Covis Pharma US, Inc)

View source ↗

Summary

The FDA approved ALVESCO (ciclesonide) nasal spray from Covis Pharma US, Inc. through an original NDA (NDA021658) for the treatment of allergic rhinitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Alvesco (ciclesonide)

Snippet

ORIG AP for ALVESCO (CICLESONIDE)